Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10214568 | Journal of Vascular Surgery | 2018 | 6 Pages |
Abstract
FEVAR with the ZFEN platform of failed and failing aortic reconstructions due to disease progression is safe and feasible without increased morbidity and mortality in select patients. These preliminary results support the inclusion of ZFEN as a treatment option for aortic reintervention.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
S. Keisin MD, Natalie A. MD, Alan P. MD, Gary W. MD, Michael C. MD, Raghu L. MD, Michael P. MD, Andres MD,